Description
Receptor Specific Formulation
This formulation is designed to activate the CB1 central
receptor in the Endocannabinoid system.
The CB1 receptor is known to be activated by Δ9-THC
and associated with pain relief and sleep aid.
Inquire here for wholesale sizes
Inquire here for wholesale sizes
This formulation is designed to activate the CB1 central
receptor in the Endocannabinoid system.
The CB1 receptor is known to be activated by Δ9-THC
and associated with pain relief and sleep aid.
Receptor-Specific™ Formulations designed to treat inflammation and pain perception
Receptor-Specific™ Formulations designed to treat inflammation and pain perception
Receptor-Specific™ Formulations designed to treat inflammation and pain perception
Our partners may engineer their own custom wellness products and achieve desired effects in various product mediums, with full R&D support from feasibility testing to white label production.
Tailor-Made To Fit Your Exact NeedsTerpene formulation based on your specific strain analysis or created from scratch according to your needs and product statement. |
30-Day DevelopmentOur dedicated development team guarantees a short turn-around time and product satisfaction. |
Optimization Per Product ApplicationAdjustment of formulation based on product’s final application and delivery system, to optimize its functionality and efficiency. |
||||||||||
|
Allowed for use as flavor ingredients intended for human consumption, or as indirect additives according to Section 21 CFR of the Federal Food, Drug and Cosmetic Act. Complies with the European Council Directive 88/388/EEC and EU Regulation 1334/2008.
Composed of only natural ingredients as defined in Section 21 CFR 101.22 and contains no artificial flavor ingredients.
Contains only natural, botanical derived molecules and does not include any cannabis-derived compounds.
Certified and supervised Kosher by the OU, the largest and most trusted Kosher certifying body in the world.
Does not consist of GMOs, contains GMOs, or produced from GMOs as defined in the EU Regulation 1829/2003 and 1830/2003
Manufactured according to the international standard for a quality management system of best practices
This formulation is designed to activate the CB1 central
receptor in the Endocannabinoid system.
The CB1 receptor is known to be activated by Δ9-THC
and associated with pain relief and sleep aid.
Capacity | 250ml / 8.4oz, 50ml / 1.7oz |
---|---|
Effects | Mood, Pain, Sleep |
Applications | Beverages, Ingestibles, Inhalation, Tincturess |
This formulation is designed to activate the Adenosine A2A receptor that is considered part of the Endocannabinoid System. A2A receptors activation affects various behaviors including locomotor activity, sleep-wake cycle, anxiety, depression, and learning and memory.